SPDE Stock Overview
Speedus Corp., through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Speedus Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.000001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | -99.99% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
SPDE | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 1.8% | 1.2% |
1Y | n/a | -0.5% | 24.9% |
Return vs Industry: Insufficient data to determine how SPDE performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SPDE performed against the US Market.
Price Volatility
SPDE volatility | |
---|---|
SPDE Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SPDE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SPDE's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | n/a | Shant Hovnanian | www.speedus.com |
Speedus Corp., through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States. The company offers computer-aided medical devices and telemedicine based delivery systems, including Zargis Cardioscan device, a non-invasive diagnostic support solution that automatically analyzes acoustical data from a patient to determine whether or not the patient possesses a suspected diastolic or systolic murmur; ZargisTelemed portal; and Signal X6 device, which records heart and lung sounds from six adhesive acoustic sensors. It also develops and markets ultra-high speed storage systems comprising JetX10 acceleration appliance, JetPod, and JetNode expansion chassis for server networks and other applications.
Speedus Corp. Fundamentals Summary
SPDE fundamental statistics | |
---|---|
Market cap | US$4.00 |
Earnings (TTM) | -US$2.80m |
Revenue (TTM) | US$550.99k |
0.0x
P/S Ratio0.0x
P/E RatioIs SPDE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SPDE income statement (TTM) | |
---|---|
Revenue | US$550.99k |
Cost of Revenue | US$133.72k |
Gross Profit | US$417.28k |
Other Expenses | US$3.22m |
Earnings | -US$2.80m |
Last Reported Earnings
Sep 30, 2010
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did SPDE perform over the long term?
See historical performance and comparison